Related Experiment Video

Updated: Aug 10, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.2K

Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?

Raymond E Soccio1

  • 1Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism; Institute for Diabetes, Obesity and Metabolism; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

The Journal of Clinical Endocrinology and Metabolism
|May 21, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Mendelian randomizationgalectin-3nonalcoholic fatty liver diseasephenome-wide association study

More Related Videos

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells09:15

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

9.1K
An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

991

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...